Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Brunner, Elizabeth; Falk, Deborah M; Jones, Meghan; Dey, Debashish K; Shatapathy, Chetan Chinmaya

Brunner, Elizabeth; Falk, Deborah M; Jones, Meghan; Dey, Debashish K; Shatapathy, Chetan Chinmaya.

Affiliation

Brunner E; Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. ebrunner@lilly.com

BMC Pharmacol Toxicol ; 14: 38, 2013 Aug 01.

Article in En | MEDLINE | ID: mdl-23902726

Subject(s)

Antipsychotic Agents/therapeutic use; Benzodiazepines/therapeutic use; Pregnancy Outcome/epidemiology; Adverse Drug Reaction Reporting Systems; Breast Feeding; Databases, Factual; Female; Humans; Olanzapine; Pharmacovigilance; Pregnancy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antipsychotic Agents / Benzodiazepines / Pregnancy Outcome Type of study: Screening_studies Limits: Female / Humans / Pregnancy Language: En Journal: BMC Pharmacol Toxicol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google